BIA
PRAX icon

Bell Investment Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Bell Investment Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Hold
5
– – ﹤0.01% 1390
2026
Q1 		$1.61K Hold
5
– – ﹤0.01% 1395
2025
Q4 		$1.47K Buy
+5
New +$931 ﹤0.01% 1442

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Bell Investment Advisors's PRAX Position: Q2 2026 in Review

Bell Investment Advisors held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 5 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

Bell Investment Advisors first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Bell Investment Advisors held 5 shares of Praxis Precision Medicines worth $1.67K as of Q2 2026.
  • Bell Investment Advisors left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1390 holding.
  • Bell Investment Advisors first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.